Clinicaltrials.gov was looked for registered study protocols. The keywords “palmitoylethanolamide” and “suffering” resulted in thirteen entries, of which three had been completed. None of them fulfilled our eligibility criteria. The anti‐inflammatory outcomes of PEA appear to be mainly connected with its capability to modulate mast cell activation and degranulation, https://canconolidinehelpwithment42852.blog5.net/71467558/5-simple-techniques-for-palmitoylethanolamide